Correlation Between Evoke Pharma and Catalent
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Catalent, you can compare the effects of market volatilities on Evoke Pharma and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Catalent.
Diversification Opportunities for Evoke Pharma and Catalent
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Evoke and Catalent is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Catalent go up and down completely randomly.
Pair Corralation between Evoke Pharma and Catalent
If you would invest (100.00) in Catalent on December 28, 2024 and sell it today you would earn a total of 100.00 from holding Catalent or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Evoke Pharma vs. Catalent
Performance |
Timeline |
Evoke Pharma |
Catalent |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Evoke Pharma and Catalent Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Evoke Pharma and Catalent
The main advantage of trading using opposite Evoke Pharma and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
Catalent vs. IQVIA Holdings | Catalent vs. West Pharmaceutical Services | Catalent vs. Charles River Laboratories | Catalent vs. Bio Rad Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |